Cai Jun, Sun Hai-yun, Shen Ning, Hei Zi-qing
Department of Anesthesiology, Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, Guangdong, China.
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Jul;23(7):396-400.
To investigate the feature of cerebral oxygen metabolism during peri-operative stage of orthotopic liver transplantation (OLT), in order to identify the difference between the patients with or without complicating encephalopathy after OLT, and the relationship between the cerebral oxygen metabolism and encephalopathy after OLT.
Thirty patients undergoing OLT were studied. The patients were divided into two groups according to occurrence or not of encephalopathy after OLT: encephalopathy group and non-encephalopathy group. Blood samples were taken from radial artery and jugular vein simultaneously for blood gas analysis before operation, 25 minutes after onset of anhepatic phase, 30 minutes after graft reperfusion , 3 hours after graft reperfusion , and 24 hours after graft reperfusion. Cerebral arterial oxygen content (CaO(2)), oxygen content of jugular vein blood (CjvO(2)), cerebral arterial-venous oxygen content difference (Ca-jvO(2)), cerebral oxygen extraction ratio (CERO(2)) and cerebral blood flow/cerebral metabolic rate of oxygen ratio (CBF/CMRO(2)) were calculated, and the levels of blood glucose and lactic acid were recorded.
There were 11 patients (36.7%) complicated by encephalopathy after OLT. The quantity of red blood cell infusion, blood loss and the dosage of noradrenalin in encephalopathy group were significantly larger compared with non-encephalopathy group. The overall tendency of change in cerebral oxygen metabolism index was about the same for both groups, while CaO(2) and Ca-jvO(2) at 25 minutes after onset of anhepatic phase, 30 minutes after graft reperfusion and 3 hours after graft reperfusion , and CERO(2) at 30 minutes after graft reperfusion and 3 hours after graft reperfusion were significantly decreased compared with those before operation [CaO(2) (ml/L) in encephalopathy group: 132.4 ± 23.5 , 125.9 ± 17.6, 133.4 ± 11.1 vs. 148.5 ± 28.8, in non-encephalopathy group: 135.7 ± 22.4, 130.5 ± 20.0, 139.9 ± 21.2 vs. 148.9 ± 28.2; Ca-jvO(2) (ml/L) in encephalopathy group: 42.9 ± 13.2, 31.4 ± 12.3 , 32.3 ± 6.5 vs. 52.9 ± 23.5, in non-encephalopathy group: 33.0 ± 14.1, 26.6 ± 9.1, 30.6 ± 10.3 vs. 50.2 ± 23.2; CERO(2) in encephalopathy group: (24.9 ± 9.7)%, (24.4 ± 5.5)% vs. (35.4 ± 11.5)%, in non-encephalopathy group: (20.6 ± 7.3)%, (21.9 ± 7.0)% vs. (33.4 ± 13.1)%, all P < 0.05], and they returned to the levels before operation at 24 hours after graft reperfusion. Jugular venous oxygen saturation (SjvO(2)) and CBF/CMRO(2) ratio were significantly increased at 30 minutes after graft reperfusion and 3 hours after graft reperfusion compared with the levels before operation [SjvO(2) in encephalopathy group: 0.838 ± 0.105, 0.835 ± 0.065 vs. 0.709 ± 0.125, in non-encephalopathy group: 0.854 ± 0.074, 0.824 ± 0.074 vs. 0.713 ± 0.138; CBF/CMRO(2) ratio in encephalopathy group: 37.8 ± 16.6, 31.9 ± 6.8 vs. 20.9 ± 6.7 , in non-encephalopathy group: 37.8 ± 14.1, 35.7 ± 13.7 vs. 24.3 ± 14.0, all P <0.05], and they returned to the levels before operation at 24 hours after graft reperfusion. The overall tendency of change in blood glucose and lactic acid was about the same in both groups, while the levels of blood glucose increased significantly from anhepatic phase to 24 hours after graft reperfusion compared with the levels before operation , and the levels of lactic acid increased significantly from anhepatic phase to 3 hours after graft reperfusion compared with the levels before operation and returned to the levels before operation at 24 hours after graft reperfusion.
There are significant changes in the features of cerebral oxygen metabolism during OLT, but there is no difference between encephalopathy group and non-encephalopathy group. The occurrence of encephalopathy can be attributed to many factors, so the prevention and treatment should be comprehensive considered.
探讨原位肝移植(OLT)围手术期脑氧代谢特点,以明确OLT术后并发脑病与未并发脑病患者之间的差异,以及脑氧代谢与OLT术后脑病的关系。
研究30例行OLT的患者。根据OLT术后是否发生脑病将患者分为两组:脑病组和非脑病组。于术前、无肝期开始25分钟后、移植肝再灌注30分钟后、移植肝再灌注3小时后及移植肝再灌注24小时后,同时从桡动脉和颈静脉采集血样进行血气分析。计算脑动脉血氧含量(CaO₂)、颈静脉血氧含量(CjvO₂)、脑动静脉血氧含量差(Ca-jvO₂)、脑氧摄取率(CERO₂)及脑血流量/脑氧代谢率比值(CBF/CMRO₂),并记录血糖和乳酸水平。
OLT术后有11例患者(36.7%)并发脑病。脑病组红细胞输注量、失血量及去甲肾上腺素用量均显著多于非脑病组。两组脑氧代谢指标的总体变化趋势大致相同,但无肝期开始25分钟后、移植肝再灌注30分钟后及移植肝再灌注3小时后的CaO₂和Ca-jvO₂,以及移植肝再灌注30分钟后及移植肝再灌注3小时后的CERO₂与术前相比均显著降低[脑病组CaO₂(ml/L):132.4±23.5、125.9±17.6、133.4±11.1,术前为148.5±28.8;非脑病组CaO₂(ml/L):135.7±22.4、130.5±20.0、139.9±21.2,术前为148.9±28.2;脑病组Ca-jvO₂(ml/L):42.9±13.2、31.4±12.3、32.3±6.5,术前为52.9±23.5;非脑病组Ca-jvO₂(ml/L):33.0±14.1、26.6±9.1、30.6±10.3,术前为50.2±23.2;脑病组CERO₂:(24.9±9.7)%、(24.4±5.5)%,术前为(35.4±11.5)%;非脑病组CERO₂:(20.6±7.3)%、(21.9±7.0)%,术前为(33.4±13.1)%,均P<0.05],且在移植肝再灌注24小时后恢复至术前水平。移植肝再灌注30分钟后及移植肝再灌注3小时后的颈静脉血氧饱和度(SjvO₂)和CBF/CMRO₂比值与术前相比显著升高[SjvO₂在脑病组:0.838±0.105、0.835±0.065,术前为0.709±0.125;非脑病组SjvO₂:0.854±0.074、0.824±0.074,术前为0.713±0.138;脑病组CBF/CMRO₂比值:37.8±16.6、31.9±6.8,术前为20.9±6.7;非脑病组CBF/CMRO₂比值:37.8±14.1、35.7±13.7,术前为24.3±14.0,均P<0.05],且在移植肝再灌注24小时后恢复至术前水平。两组血糖和乳酸的总体变化趋势大致相同,但与术前相比,无肝期至移植肝再灌注后24小时血糖水平显著升高,无肝期至移植肝再灌注后3小时乳酸水平显著升高,并在移植肝再灌注24小时后恢复至术前水平。
OLT期间脑氧代谢特点有显著变化,但脑病组与非脑病组之间无差异。脑病的发生可归因于多种因素,因此预防和治疗应综合考虑。